Overcoming the limitations in microalgae research, a cutting-edge one-vector episomal CRISPR/Cas9 system has been developed for Nannochloropsis oceanica CCMP1779. This system allows the creation of marker-free mutant lines, crucial for field deployment and regulatory compliance. By including the CEN/ARS6 region from Saccharomyces cerevisiae in the vector, circular extrachromosomal DNA is maintained. With a bidirectional promoter, the vector produces Cas9 and sgRNA, enabling efficient targeted mutations. After selection pressure is removed, the episomal DNA can be eliminated, resulting in marker-free nontransgenic engineered lines. This breakthrough technology holds significant promise for advancing microalgal lipid metabolism studies and industrial applications.
Microalgae have untapped potential but are hindered by a lack of effective tools to create loss-of-function mutants. Additionally, for field deployment, modified strains must be free of antibiotic resistance genes and face fewer regulatory hurdles as transgene-free organisms.
Nannochloropsis oceanica CCMP1779, an oleaginous microalga, is emerging as a valuable model for studying microalgal lipid metabolism. Its unique properties make it an ideal candidate for advancements in genetic engineering.
We introduce a cutting-edge one-vector episomal CRISPR/Cas9 system designed specifically for Nannochloropsis oceanica. This innovative system allows for the generation of marker-free mutant lines.
The vector used in this system includes the CEN/ARS6 region from Saccharomyces cerevisiae, ensuring the maintenance of the circular extrachromosomal DNA. With a bidirectional promoter, the vector produces both Cas9 and a ribozyme-flanked sgRNA. This powerful combination efficiently generates targeted mutations.
One significant advantage of our system is the ability to remove the episomal DNA after selection pressure is eliminated, resulting in marker-free nontransgenic engineered lines. This feature ensures the absence of unwanted genetic material, allowing for safer and more efficient applications.
To validate the effectiveness of this system, we successfully disrupted the nitrate reductase gene (NR) in Nannochloropsis oceanica CCMP1779. Subsequently, we removed the CRISPR episome, resulting in the generation of nontransgenic marker-free nitrate reductase knockout lines (NR-KO).
2444 Dole Street
Honolulu, HI 96822